Shares of Hims & Hers Health Inc. (HIMS) tumbled 5.03% in pre-market trading on Wednesday, following the company's first-quarter earnings report and subsequent guidance update. The health and wellness company's stock movement comes as a surprise, given its impressive 18.1% surge in the previous trading session.

Hims & Hers Health reported first-quarter earnings that topped Wall Street estimates, showcasing the company's strong performance in the near term. However, investors seem to be focusing on the company's long-term outlook, which fell short of expectations. For the second quarter, Hims & Hers expects revenue between $530 million to $550 million, significantly below analysts' expectations of $564.6 million.

This pre-market plunge highlights the market's sensitivity to forward-looking guidance, especially for growth-oriented companies in the health and wellness sector. Despite the company's ability to beat current quarter estimates, the lower long-term sales projection has sparked concerns among investors about the company's future growth trajectory. As the market digests this information, it remains to be seen how Hims & Hers Health will navigate these expectations and maintain investor confidence in the coming quarters.